Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.
Identifieur interne : 000351 ( Main/Exploration ); précédent : 000350; suivant : 000352Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.
Auteurs : Karen L. Laurie [Australie] ; Patricia Huston ; Steven Riley ; Jacqueline M. Katz ; Donald J. Willison ; John S. Tam ; Anthony W. Mounts ; Katja Hoschler ; Elizabeth Miller ; Kaat Vandemaele ; Eeva Broberg ; Maria D. Van Kerkhove ; Angus NicollSource :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- MESH :
- geographic , epidemiology : Canada.
- epidemiology : Influenza, Human.
- methods : Disease Notification, Public Health.
- Epidemiological Monitoring, Humans, Practice Guidelines as Topic, Serologic Tests.
Abstract
BACKGROUND
Serological studies can detect infection with a novel influenza virus in the absence of symptoms or positive virology, providing useful information on infection that goes beyond the estimates from epidemiological, clinical and virological data. During the 2009 A(H1N1) pandemic, an impressive number of detailed serological studies were performed, yet the majority of serological data were available only after the first wave of infection. This limited the ability to estimate the transmissibility and severity of this novel infection, and the variability in methodology and reporting limited the ability to compare and combine the serological data.
OBJECTIVES
To identify best practices for conduct and standardisation of serological studies on outbreak and pandemic influenza to inform public policy.
METHODS/SETTING
An international meeting was held in February 2011 in Ottawa, Canada, to foster the consensus for greater standardisation of influenza serological studies.
RESULTS
Best practices for serological investigations of influenza epidemiology include the following: classification of studies as pre-pandemic, outbreak, pandemic or inter-pandemic with a clearly identified objective; use of international serum standards for laboratory assays; cohort and cross-sectional study designs with common standards for data collection; use of serum banks to improve sampling capacity; and potential for linkage of serological, clinical and epidemiological data. Advance planning for outbreak studies would enable a rapid and coordinated response; inclusion of serological studies in pandemic plans should be considered.
CONCLUSIONS
Optimising the quality, comparability and combinability of influenza serological studies will provide important data upon emergence of a novel or variant influenza virus to inform public health action.
DOI: 10.1111/j.1750-2659.2012.0370a.x
PubMed: 22548725
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.</title><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Vic. 3051, Australia. karen.laurie@influenzacentre.org</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Vic. 3051</wicri:regionArea><wicri:noRegion>Vic. 3051</wicri:noRegion></affiliation></author><author><name sortKey="Huston, Patricia" sort="Huston, Patricia" uniqKey="Huston P" first="Patricia" last="Huston">Patricia Huston</name></author><author><name sortKey="Riley, Steven" sort="Riley, Steven" uniqKey="Riley S" first="Steven" last="Riley">Steven Riley</name></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name></author><author><name sortKey="Willison, Donald J" sort="Willison, Donald J" uniqKey="Willison D" first="Donald J" last="Willison">Donald J. Willison</name></author><author><name sortKey="Tam, John S" sort="Tam, John S" uniqKey="Tam J" first="John S" last="Tam">John S. Tam</name></author><author><name sortKey="Mounts, Anthony W" sort="Mounts, Anthony W" uniqKey="Mounts A" first="Anthony W" last="Mounts">Anthony W. Mounts</name></author><author><name sortKey="Hoschler, Katja" sort="Hoschler, Katja" uniqKey="Hoschler K" first="Katja" last="Hoschler">Katja Hoschler</name></author><author><name sortKey="Miller, Elizabeth" sort="Miller, Elizabeth" uniqKey="Miller E" first="Elizabeth" last="Miller">Elizabeth Miller</name></author><author><name sortKey="Vandemaele, Kaat" sort="Vandemaele, Kaat" uniqKey="Vandemaele K" first="Kaat" last="Vandemaele">Kaat Vandemaele</name></author><author><name sortKey="Broberg, Eeva" sort="Broberg, Eeva" uniqKey="Broberg E" first="Eeva" last="Broberg">Eeva Broberg</name></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name></author><author><name sortKey="Nicoll, Angus" sort="Nicoll, Angus" uniqKey="Nicoll A" first="Angus" last="Nicoll">Angus Nicoll</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:22548725</idno><idno type="pmid">22548725</idno><idno type="doi">10.1111/j.1750-2659.2012.0370a.x</idno><idno type="wicri:Area/Main/Corpus">000438</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000438</idno><idno type="wicri:Area/Main/Curation">000438</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000438</idno><idno type="wicri:Area/Main/Exploration">000438</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.</title><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Vic. 3051, Australia. karen.laurie@influenzacentre.org</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Vic. 3051</wicri:regionArea><wicri:noRegion>Vic. 3051</wicri:noRegion></affiliation></author><author><name sortKey="Huston, Patricia" sort="Huston, Patricia" uniqKey="Huston P" first="Patricia" last="Huston">Patricia Huston</name></author><author><name sortKey="Riley, Steven" sort="Riley, Steven" uniqKey="Riley S" first="Steven" last="Riley">Steven Riley</name></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name></author><author><name sortKey="Willison, Donald J" sort="Willison, Donald J" uniqKey="Willison D" first="Donald J" last="Willison">Donald J. Willison</name></author><author><name sortKey="Tam, John S" sort="Tam, John S" uniqKey="Tam J" first="John S" last="Tam">John S. Tam</name></author><author><name sortKey="Mounts, Anthony W" sort="Mounts, Anthony W" uniqKey="Mounts A" first="Anthony W" last="Mounts">Anthony W. Mounts</name></author><author><name sortKey="Hoschler, Katja" sort="Hoschler, Katja" uniqKey="Hoschler K" first="Katja" last="Hoschler">Katja Hoschler</name></author><author><name sortKey="Miller, Elizabeth" sort="Miller, Elizabeth" uniqKey="Miller E" first="Elizabeth" last="Miller">Elizabeth Miller</name></author><author><name sortKey="Vandemaele, Kaat" sort="Vandemaele, Kaat" uniqKey="Vandemaele K" first="Kaat" last="Vandemaele">Kaat Vandemaele</name></author><author><name sortKey="Broberg, Eeva" sort="Broberg, Eeva" uniqKey="Broberg E" first="Eeva" last="Broberg">Eeva Broberg</name></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name></author><author><name sortKey="Nicoll, Angus" sort="Nicoll, Angus" uniqKey="Nicoll A" first="Angus" last="Nicoll">Angus Nicoll</name></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Canada (epidemiology)</term><term>Disease Notification (methods)</term><term>Epidemiological Monitoring</term><term>Humans</term><term>Influenza, Human (epidemiology)</term><term>Practice Guidelines as Topic</term><term>Public Health (methods)</term><term>Serologic Tests</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Canada (épidémiologie)</term><term>Grippe humaine (épidémiologie)</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Notification des maladies à déclaration obligatoire ()</term><term>Santé publique ()</term><term>Tests sérologiques</term><term>Épidémiosurveillance</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Disease Notification</term><term>Public Health</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Epidemiological Monitoring</term><term>Humans</term><term>Practice Guidelines as Topic</term><term>Serologic Tests</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Notification des maladies à déclaration obligatoire</term><term>Santé publique</term><term>Tests sérologiques</term><term>Épidémiosurveillance</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Serological studies can detect infection with a novel influenza virus in the absence of symptoms or positive virology, providing useful information on infection that goes beyond the estimates from epidemiological, clinical and virological data. During the 2009 A(H1N1) pandemic, an impressive number of detailed serological studies were performed, yet the majority of serological data were available only after the first wave of infection. This limited the ability to estimate the transmissibility and severity of this novel infection, and the variability in methodology and reporting limited the ability to compare and combine the serological data.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b></p><p> To identify best practices for conduct and standardisation of serological studies on outbreak and pandemic influenza to inform public policy.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS/SETTING</b></p><p>An international meeting was held in February 2011 in Ottawa, Canada, to foster the consensus for greater standardisation of influenza serological studies.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Best practices for serological investigations of influenza epidemiology include the following: classification of studies as pre-pandemic, outbreak, pandemic or inter-pandemic with a clearly identified objective; use of international serum standards for laboratory assays; cohort and cross-sectional study designs with common standards for data collection; use of serum banks to improve sampling capacity; and potential for linkage of serological, clinical and epidemiological data. Advance planning for outbreak studies would enable a rapid and coordinated response; inclusion of serological studies in pandemic plans should be considered.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Optimising the quality, comparability and combinability of influenza serological studies will provide important data upon emergence of a novel or variant influenza virus to inform public health action.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22548725</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.</ArticleTitle><Pagination><MedlinePgn>211-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1750-2659.2012.0370a.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Serological studies can detect infection with a novel influenza virus in the absence of symptoms or positive virology, providing useful information on infection that goes beyond the estimates from epidemiological, clinical and virological data. During the 2009 A(H1N1) pandemic, an impressive number of detailed serological studies were performed, yet the majority of serological data were available only after the first wave of infection. This limited the ability to estimate the transmissibility and severity of this novel infection, and the variability in methodology and reporting limited the ability to compare and combine the serological data.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE"> To identify best practices for conduct and standardisation of serological studies on outbreak and pandemic influenza to inform public policy.</AbstractText><AbstractText Label="METHODS/SETTING" NlmCategory="METHODS">An international meeting was held in February 2011 in Ottawa, Canada, to foster the consensus for greater standardisation of influenza serological studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Best practices for serological investigations of influenza epidemiology include the following: classification of studies as pre-pandemic, outbreak, pandemic or inter-pandemic with a clearly identified objective; use of international serum standards for laboratory assays; cohort and cross-sectional study designs with common standards for data collection; use of serum banks to improve sampling capacity; and potential for linkage of serological, clinical and epidemiological data. Advance planning for outbreak studies would enable a rapid and coordinated response; inclusion of serological studies in pandemic plans should be considered.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Optimising the quality, comparability and combinability of influenza serological studies will provide important data upon emergence of a novel or variant influenza virus to inform public health action.</AbstractText><CopyrightInformation>© 2012 Blackwell Publishing Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laurie</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Vic. 3051, Australia. karen.laurie@influenzacentre.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huston</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jacqueline M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Willison</LastName><ForeName>Donald J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>John S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Mounts</LastName><ForeName>Anthony W</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Hoschler</LastName><ForeName>Katja</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Vandemaele</LastName><ForeName>Kaat</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Broberg</LastName><ForeName>Eeva</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Van Kerkhove</LastName><ForeName>Maria D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Nicoll</LastName><ForeName>Angus</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/K010174/1</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018563" MajorTopicYN="N">Disease Notification</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="Y">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22548725</ArticleId><ArticleId IdType="doi">10.1111/j.1750-2659.2012.0370a.x</ArticleId><ArticleId IdType="pmc">PMC5855149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2009 Aug 8;374(9688):451-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19643469</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Oct 22;14(42):null</Citation><ArticleIdList><ArticleId IdType="pubmed">19883544</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Sep 07;5(9):e12562</Citation><ArticleIdList><ArticleId IdType="pubmed">20830210</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Aug 30;5(8):e12474</Citation><ArticleIdList><ArticleId IdType="pubmed">20814575</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Apr 30;28(20):3558-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20307592</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2010 Jun 10;10:164</Citation><ArticleIdList><ArticleId IdType="pubmed">20537158</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 May 21;28(23):3929-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20394719</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2010 May;16(5):874-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20409391</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2010 Nov 1;202(9):1319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">20863233</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2010 Oct;16(10):1554-61</Citation><ArticleIdList><ArticleId IdType="pubmed">20875280</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e21828</Citation><ArticleIdList><ArticleId IdType="pubmed">21850217</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2006 Dec;134(6):1208-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16690000</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Apr 14;303(14):1383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20388894</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jul 24;325(5939):481-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19574348</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2010 Aug 10;4(8):e787</Citation><ArticleIdList><ArticleId IdType="pubmed">20706628</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Nov 11;15(45):null</Citation><ArticleIdList><ArticleId IdType="pubmed">21087590</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2012 May;6(3):e48-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22353441</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2000 Feb;29(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">10750597</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2011 Jun;49(6):2210-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21471339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2008 Mar;86(3):197-204</Citation><ArticleIdList><ArticleId IdType="pubmed">18368206</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Ethics. 2011 Nov;37(11):668-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21613648</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jun 19;324(5934):1557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19433588</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 1;51(9):1033-41</Citation><ArticleIdList><ArticleId IdType="pubmed">20887206</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2011 Jan 17;194(2):68-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21241219</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1994 Feb;12(2):167-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8147099</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2011 Dec;32(12):1149-57</Citation><ArticleIdList><ArticleId IdType="pubmed">22080652</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health. 2010 Jan;124(1):14-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20141821</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2011 Sep;17(9):1615-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21888786</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jul 24;325(5939):484-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19574347</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 May 16;25(20):4056-63</Citation><ArticleIdList><ArticleId IdType="pubmed">17412461</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Dec 17;361(25):2414-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19846844</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2007 Oct 16;4(10):e296</Citation><ArticleIdList><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2010 Jul;65(7):645-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20627925</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Feb 04;15(5):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20144443</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2011 Mar 04;11 Suppl 2:S10</Citation><ArticleIdList><ArticleId IdType="pubmed">21388561</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2000 Jan 8;320(7227):90-1</Citation><ArticleIdList><ArticleId IdType="pubmed">10625262</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 2008 Jan;102(1):70-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17996913</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1989 Nov 25;299(6711):1295-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2513926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19478718</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Sep;53(5):455-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21844028</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Apr 10;324(5924):246-51</Citation><ArticleIdList><ArticleId IdType="pubmed">19251591</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Oct 5;182(14):1522-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20823167</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2010 Aug 25;10:255</Citation><ArticleIdList><ArticleId IdType="pubmed">20738878</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chin Med Assoc. 2010 Feb;73(2):62-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20171584</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Jun 01;7(6):e1000275</Citation><ArticleIdList><ArticleId IdType="pubmed">20532237</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21692672</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Jan 15;50(2):285-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20034356</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Immunol. 1986;30(11):1141-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3807793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Aug 20;460(7258):1021-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19672242</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1925-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19815860</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Apr 21;6(4):e17919</Citation><ArticleIdList><ArticleId IdType="pubmed">21533034</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Dec 31;361(27):2628-36</Citation><ArticleIdList><ArticleId IdType="pubmed">20042754</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 1979 Jan;35(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">367490</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Jul;8(7):e1001053</Citation><ArticleIdList><ArticleId IdType="pubmed">21750667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2009 Mar;16(3):265-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19234466</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Jun 10;362(23 ):2175-2184</Citation><ArticleIdList><ArticleId IdType="pubmed">20558368</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19918065</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Oct 07;15(40):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20946757</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2010 Dec;17(12):1958-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20876823</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Aug 05;15(31):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20738992</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Technol Assess. 2010 Dec;14 (55):115-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21208549</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2011 Aug;18(8):1205-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21653743</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Aug;15(8):1252-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19751587</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth J Med. 2009 Jul-Aug;67(7):301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19687529</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1982 Aug;116(2):228-42</Citation><ArticleIdList><ArticleId IdType="pubmed">7114034</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Dec 15;51(12):1465-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21082879</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2011 Sep;17(9):1670-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21888793</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2000 Apr;29(2):362-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10817137</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Jul 09;14(27):null</Citation><ArticleIdList><ArticleId IdType="pubmed">19589330</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Oct 14;5(10):e13211</Citation><ArticleIdList><ArticleId IdType="pubmed">20976224</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1972 Dec;70(4):767-77</Citation><ArticleIdList><ArticleId IdType="pubmed">4509641</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Jul 1;51(1):70-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20482372</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Jun;8(6):e1000442</Citation><ArticleIdList><ArticleId IdType="pubmed">21713000</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Nov;15(11):1849-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19891883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Australie</li></country></list><tree><noCountry><name sortKey="Broberg, Eeva" sort="Broberg, Eeva" uniqKey="Broberg E" first="Eeva" last="Broberg">Eeva Broberg</name><name sortKey="Hoschler, Katja" sort="Hoschler, Katja" uniqKey="Hoschler K" first="Katja" last="Hoschler">Katja Hoschler</name><name sortKey="Huston, Patricia" sort="Huston, Patricia" uniqKey="Huston P" first="Patricia" last="Huston">Patricia Huston</name><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><name sortKey="Miller, Elizabeth" sort="Miller, Elizabeth" uniqKey="Miller E" first="Elizabeth" last="Miller">Elizabeth Miller</name><name sortKey="Mounts, Anthony W" sort="Mounts, Anthony W" uniqKey="Mounts A" first="Anthony W" last="Mounts">Anthony W. Mounts</name><name sortKey="Nicoll, Angus" sort="Nicoll, Angus" uniqKey="Nicoll A" first="Angus" last="Nicoll">Angus Nicoll</name><name sortKey="Riley, Steven" sort="Riley, Steven" uniqKey="Riley S" first="Steven" last="Riley">Steven Riley</name><name sortKey="Tam, John S" sort="Tam, John S" uniqKey="Tam J" first="John S" last="Tam">John S. Tam</name><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><name sortKey="Vandemaele, Kaat" sort="Vandemaele, Kaat" uniqKey="Vandemaele K" first="Kaat" last="Vandemaele">Kaat Vandemaele</name><name sortKey="Willison, Donald J" sort="Willison, Donald J" uniqKey="Willison D" first="Donald J" last="Willison">Donald J. Willison</name></noCountry><country name="Australie"><noRegion><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000351 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000351 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22548725
|texte= Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22548725" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |